Side effects from use of one or more psychiatric medications in a population-based sample of children and adolescents

Journal of Child and Adolescent Psychopharmacology

Volumn 24, Issue 2, 2014, Pages 83-89

  Hilt, Robert J ^a   Chaudhari, Monica ^b   Bell, Janice F ^c   Wolf, Christine ^b   Koprowicz, Kent ^b   King, Bryan H ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Axio Research LLC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CENTRAL STIMULANT AGENT; MOOD STABILIZER; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR; PSYCHOTROPIC AGENT;

ADOLESCENT; ARTICLE; CHILD; DECREASED APPETITE; DISEASE SEVERITY; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; INCREASED APPETITE; INSOMNIA; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; OUTCOME VARIABLE; PHARMACY; PRESCRIPTION; PRIVATE HEALTH INSURANCE; QUESTIONNAIRE; RACE DIFFERENCE; SCHOOL CHILD; SEX DIFFERENCE; SIDE EFFECT; SOMNOLENCE; TIC; TREMOR; HEALTH CARE DELIVERY; LONGITUDINAL STUDY; POLYPHARMACY; PRESCHOOL CHILD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; LONGITUDINAL STUDIES; MALE; POLYPHARMACY; PSYCHOTROPIC DRUGS;

EID: 84897416925     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.2013.0036     Document Type: Article

References (21)

1. Achenbach TM, Rescorla LA: Manual for the ASEBA School-Age Forms and Profiles. Burlington, VT: ASEBA; 2001.
2. American Academy of Child and Adolescent Psychiatry (AACAP) Workgroup on Quality Issues: Practice parameter on the use of psychotropic medication in children and adolescents. J Am Acad Child Adolesc Psychiatry 48:961-973, 2009.
3. Asch DA, Jedrziewski MK, Christakis NA: Response rates to mail surveys published in medical journals. J Clin Epidemiol 50:1129-1136, 1997.
4. Becker A, Woerner W, Hasselhorn M, Banaschewski T, Rothenberger A: Validation of the parent and teacher SDQ in a clinical sample. Eur Child Adolesc Psychiatry 13(Suppl 2):II11-II16, 2004.
5. Bobo WV, Cooper WO, Stein M, Olfson M, Graham D, Daugherty J, Fuchs C, Ray WA: Antipsychotics and the risk of type 2 diabetes mellitus in children and youth. JAMA Psychiatry 70:1067-1065, 2013.
6. Breland-Noble AM, Elbogen EB, Farmer EM, Dubs MS, Wagner HR, Burns BJ: Use of psychotropic medications by youths in therapeutic foster care and group homes. Psychiatr Serv 55:706-708, 2004.
7. Bufferd SJ, Dougherty LR, Carlson GA, Klein DN: Parent-reported mental health in preschoolers: findings using a diagnostic interview. Compr Psychiatry 52:359-369, 2011.
8. Comer JS, Olfson M, Mojtabai R: National trends in child and adolescent psychotropic polypharmacy in office based practice, 1996-2007. J Am Acad Child Adolesc Psychiatry 49:1001-1010, 2010.
9. Greenhill LL, Vitiello B, Fisher P, Levine J, Davies M, Abikoff H, Chrisman AK, Chuang S, Findling RL, March J, Scahill L, Walkup J, Riddle MA: Comparison of increasingly detailed elicitation methods for the assessment of adverse events in pediatric psychopharmacol-ogy. J Am Acad Child Adolesc Psychiatry 43:1488-1496, 2004.
10. Hammad TA, Laughren T, Racoosin J: Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry 63: 332-339, 2006.
11. Harrington CA, Garcia AS, Sircar-Ramsewak F: Evaluation of adverse drug event information in US manufacturer labels. Current Drug Safety 6:30-35, 2011.
12. Hughes RA, Wright MD, Peterson K: Flashpoint: Children, Adolescents and Psychiatric Medications. Arizona Health Futures, St. Luke's Health Initiatives website, 2006. Available at http://slhi.org/pdfs/issue-briefs/ib-2006-August.pdf Accessed November 24, 2012.
13. Jabine TB, Straf ML, Tanur JM, Tourangeau R, Committee on National Statistics at US National Research Council: Cognitive Aspects of Survey Methodology: Building a Bridge Between Disciplines. Committee on National Statistics. Washington, DC: National Academy Press; 1984.
14. Jensen PS, Bhatara VS, Vitiello B, Hoagwood K, Feil M, Burke LB: Psychoactive medication prescribing practices for U.S. children: Gaps between research and clinical practice. J Am Acad Child Adolesc Psychiatry 38:557-565, 1999.
15. Markoff J: Unreported side effects of drugs are found using internet search data, study finds. New York Times, March 6, 2013.
16. McClellan JM, Werry JS: Evidence-based treatments in child and adolescent psychiatry: An inventory. J Am Acad Child Adolesc Psychiatry 42:1388-1400, 2003.
17. Micromedex 2.0, Drug interactions database, Truven Health Analytics, Inc., 2013. Available at http://www.micromedexsolutions.com Accessed May 11, 2013.
18. National Association of State Mental Health Program Directors (NASMHPD): Technical Report on Psychiatric Polypharmacy. NASMHPD web site 2001. Available at http://www.nasmhpd.org/docs/publications/archiveDocs/2001/Polypharmacy.PDF Accessed November 24, 2012.
19. Olfson M, Marcus SC, Weissman MM, Jensen PS: National trends in the use of psychotropic medications by children. J Am Acad Child Adolesc Psychiatry 41:514-521, 2002.
20. Physicians' desk reference. (67th ed.). Montvale, NJ: PDR Network 2013.
21. Zonfrillo MR, Penn JV, Leonard HL: Pediatric psychotropic poly-pharmacy. Psychiatry 2:14-19, 2005.